THE COMPANY/THE MISSION
Removing Bottlenecks in Synthetic Biology With Cell-Free Synthesis of Long and Complex DNA
Elegen’s mission to unlock the promise of synthetic biology by eliminating a critical bottleneck in the supply of synthetic DNA
THE TECHNOLOGY, PART 1
Podcast: Solving Major Bottlenecks in Genetic Medicine and SynBio With DNA Synthesis Innovation
Matt Hill, founder and CEO of Elegen, talks about Elegen’s innovative, cell-free technologies that allow it to synthesize DNA with unprecedented speed, length, and quality.
THE TECHNOLOGY, PART 2
Elegen’s Cell-Free DNA Synthesis Speeds the Discovery and Development of Genetic Medicines
About Elegen’s cell-free DNA synthesis technology ENFINIA DNA, and how it changes the paradigm of discovery and development for genetic medicines
CASE STUDY
